• Press Release

Mount Sinai Names Scott Scheinin, MD, as Director for Lung Failure and Transplantation

Scheinin will launch Mount Sinai’s new Lung Transplant Program – one of the few in New York City

  • New York, NY
  • (June 24, 2022)

Scott Scheinin, MD, FACS, has joined Mount Sinai Health System as the Director of Lung Transplantation.  The world-renowned surgeon will launch Mount Sinai’s new Lung Failure and Transplant Program, giving patients new options for life-saving lung procedures. Mount Sinai is one of only a few sites in New York City to offer lung transplants. The new program has unique aspects including: treating all types of lung failure; collaboration with Mount Sinai’s Department of Pulmonary Medicine and Critical Care; and access to resources from Recanati/Miller Transplant Institute at Mount Sinai, which is one of the largest and most comprehensive transplantation centers in the country; and involves the Mount Sinai – National Jewish Health Respiratory Institute, a national leader in expertise and diagnosing all forms of respiratory illness and lung disease.

“I am excited for the unique opportunity to establish a comprehensive program for pulmonary failure and transplantation at Mount Sinai to address the underserved regional needs of an increasing patient demographic,” says Dr. Scheinin. “I bring decades of experience caring for critically ill patients and provide a unique clinical and research-based approach to treating their diseases.”

“We are thrilled to welcome Dr. Scheinin and launch this important transplant program, expanding our life-saving work to patients across the tri-state area,” says David Reich, MD, President of The Mount Sinai Hospital and Mount Sinai Queens. “Dr. Scheinin brings a unique and outstanding skillset to Mount Sini and his expertise and his direction of this new program further demonstrates our commitment to exceptional patient care.”

Dr. Scheinin has performed approximately one thousand lung transplants, among the most in the United States. He is one of only a few surgeons in the world dedicated to performing lung transplants without blood transfusions. This highly specialized technique can lead to quicker recovery, and helps reduce the chance of lung injury, and lessens the risk of infection, heart attack and stroke after surgery. Bloodless transplants were developed to care for certain religious groups whose beliefs do not allow for blood transfusions, but this technique is now applied to nearly all patients.

Mount Sinai’s first double lung transplant took place on Thursday, March 3, and was led by Dr. Scheinin. The lung transplant recipient is a 58-year-old professional chef from Whitestone, New York with lung disease due to silicosis. His lung disease is related to exposure at the World Trade Center during 9/11 where he was handing out meals at Ground Zero to the first responders. Prior to becoming ill, the patient was a contestant on Iron Chef America.

Dr. Scheinin also brings vast experience in multi-organ transplants to Mount Sinai, performing combined heart-lung, lung-liver, and lung-kidney transplants. This makes Mount Sinai one of the only centers in New York City to offer these complex procedures.  Dr. Scheinin is also one of the few surgeons in the country with experience in lung transplantation for HIV-positive patients.

Dr. Scheinin has a broad experience as both a cardiac and thoracic surgeon, joining both Mount Sinai’s Departments of Cardiovascular and Thoracic Surgery. This expertise is important considering many lung transplant patients present with additional cardiac pathologies, including coronary artery disease, valvular abnormalities or intracardiac shunts. His broad training and experience allows him to address these coexisting problems either before or concomitantly at the time of transplantation.

Dr. Scheinin comes to Mount Sinai after spending more than 30 years at Houston Methodist Hospital in Texas, formerly affiliated with Baylor College of Medicine, where he served as surgical director of the lung and heart transplant programs. He was most recently the director of thoracic surgery and the lung transplant program at Montefiore Health System.

Dr. Scheinin also brings his dedicated pulmonary team to Mount Sinai that he has worked with for more two decades on complex cases. His long-term colleague, Harish Seethamraju, MD, joins him as the Medical Director of the Lung Failure and Transplantation program. They have combined experience of caring for more than one-thousand pulmonary transplant patients.

"Dr. Scheinin is not only an experienced lung transplant surgeon, but he also brings with him a wealth of experience in lung transplantation and is joined by his medical partner and a an experienced transplant pulmonologist, Dr Harish Seethamraju," says Sander S. Florman, MD, Director of the Recanati/Miller Transplantation Institute at Mount Sinai. "His recruitment gives Mount Sinai the ability to offer life-saving lung transplantation as an option to our patients in need. We are excited to add the lung program to the comprehensive transplantation services here."

The team has now completed seven lung transplants since the milestone surgery in March. For more information on Mount Sinai’s Lung Transplant Program click on the link below: https://www.mountsinai.org/care/transplant/services/lung.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in 4 out of 10 pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.